Morgan Stanley Warns Investors on Palantir Stock Valuation Morgan Stanley has issued a nuanced warning to Palantir Technologies investors, emphasizing that while the firm maintains its equal-weight rating and $205 price target, the stock’s current valuation presents significant challenges. Despite strong recent performance, the bank’s analysis suggests Palantir’s shares are priced for perfection, and any deviation from expected outcomes could lead to a sharp decline. The firm’s note highlights that Palantir is trading at 64 times its 2027 free cash flow estimate and 38 times its 2027 sales projections. These multiples reflect a market that has already factored in years of flawless execution, yet the stock has remained relatively flat despite impressive quarterly results. In the fourth quarter, Palantir reported 70% year-over-year revenue growth, marking its 10th consecutive quarter of accelerating expansion. Management also raised its 2026 revenue guidance to 61% growth, with operating margins expanding to 57.5%. However, Morgan Stanley argues that even stronger-than-expected performance may be required for shares to move meaningfully higher in the near term. The bank’s long-term projections are more optimistic, forecasting earnings per share to rise from $0.75 in 2025 to $1.92 by 2027, with revenue growing at a 39% compound annual rate through 2030. Operating margins are expected to reach 68%, reinforcing the firm’s belief in Palantir’s potential. Yet, Morgan Stanley warns that the current valuation assumes sustained execution, and any slowdown in growth, margin compression, or cooling demand for enterprise AI solutions could undermine the stock’s appeal.#morgan_stanley #palantir_technologies #ontology_technology #u_s_intelligence_agencies #nato_allies
